At the third visit, the appropriate section of the Data Collection Sheet will be completed and 13 ml of blood will be drawn and processed as previously outlined. The subject will be given a 6 week supply of the second medication (as previously determined by first randomization scheme) and scheduled for follow-up in 6 weeks.